Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer

被引：0
|
作者：
A Larsson
M E Johansson
S Wangefjord
A Gaber
B Nodin
P Kucharzewska
C Welinder
M Belting
J Eberhard
A Johnsson
M Uhlén
K Jirström
机构：
[1] Lund University,Department of Clinical Sciences, Division of Pathology
[2] Skåne University Hospital,Department of Laboratory Medicine
[3] Center for Molecular Pathology,Department of Clinical Sciences, Division of Oncology
[4] Lund University,Department of Proteomics
[5] Skåne University Hospital,undefined
[6] Lund University,undefined
[7] Skåne University Hospital,undefined
[8] AlbaNova University Center,undefined
[9] Royal Institute of Technology,undefined
[10] Science for Life Laboratory,undefined
[11] Royal Institute of Technology,undefined
来源：
British Journal of Cancer | 2011年 / 105卷
关键词：
podocalyxin-like; prognosis; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：666 / 672
页数：6
相关论文
共 50 条
  • [21] Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells
    Amo, Laura
    Tamayo-Orbegozo, Estibaliz
    Maruri, Natalia
    Buque, Aitziber
    Solaun, Miren
    Rinon, Marta
    Arrieta, Arantza
    Larrucea, Susana
    CANCER LETTERS, 2015, 368 (01) : 26 - 35
  • [22] Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer
    Lee, Wen-Ying
    Kuo, Chih-Chia
    Lin, Bo-Xing
    Cheng, Chia-Hsiung
    Chen, Ku-Chung
    Lin, Cheng-Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [23] Podocalyxin-like protein 1 vascular expression in normal and malignant colon
    Tarlow, B. D.
    Rangell, L.
    Koeppen, H. K.
    JOURNAL OF PATHOLOGY, 2006, 210 : 43 - 43
  • [24] Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer
    Masami Ueda
    Tomohiro Iguchi
    Sho Nambara
    Tomoko Saito
    Hisateru Komatsu
    Shotaro Sakimura
    Hidenari Hirata
    Ryutaro Uchi
    Yuki Takano
    Yoshiaki Shinden
    Hidetoshi Eguchi
    Takaaki Masuda
    Keishi Sugimachi
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    Koshi Mimori
    Annals of Surgical Oncology, 2015, 22 : 1490 - 1498
  • [25] Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer
    Ueda, Masami
    Iguchi, Tomohiro
    Nambara, Sho
    Saito, Tomoko
    Komatsu, Hisateru
    Sakimura, Shotaro
    Hirata, Hidenari
    Uchi, Ryutaro
    Takano, Yuki
    Shinden, Yoshiaki
    Eguchi, Hidetoshi
    Masuda, Takaaki
    Sugimachi, Keishi
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    Mimori, Koshi
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1490 - S1498
  • [26] Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT
    Xu, Y.
    Pan, Z-G
    Shu, L.
    Li, Q-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (24) : 8664 - 8674
  • [27] Molecular identification of canine podocalyxin-like protein 1 as a renal tubulogenic regulator
    Cheng, HY
    Lin, YY
    Yu, CY
    Chen, JY
    Shen, KF
    Lin, WL
    Liao, HK
    Chen, YJ
    Liu, CH
    Pang, VF
    Jou, TS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06): : 1612 - 1622
  • [28] Podocalyxin-Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway
    Chen, Wei-Ju
    Huang, Wei-Kai
    Pather, Sarshan R.
    Chang, Wei-Fang
    Sung, Li-Ying
    Wu, Han-Chung
    Liao, Mei-Ying
    Lee, Chi-Chiu
    Wu, Hsuan-Hui
    Wu, Chung-Yi
    Liao, Kuo-Shiang
    Lin, Chun-Yu
    Yang, Shang-Chih
    Lin, Hsuan
    Lai, Pei-Lun
    Ng, Chi-Hou
    Hu, Chun-Mei
    Chen, I-Chih
    Chuang, Chi-Hsuan
    Lai, Chien-Ying
    Lin, Po-Yu
    Lee, Yueh-Chang
    Schuyler, Scott C.
    Schambach, Axel
    Lu, Frank Leigh
    Lu, Jean
    ADVANCED SCIENCE, 2023, 10 (01)
  • [29] Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
    Heby, Margareta
    Elebro, Jakob
    Nodin, Bjorn
    Jirstom, Karin
    Eberhard, Jakob
    BMC CLINICAL PATHOLOGY, 2015, 15
  • [30] Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
    Heby, Margareta
    Karnevi, Emelie
    Elebro, Jacob
    Nodin, Bjorn
    Eberhard, Jakob
    Saukkonen, Kapo
    Hagstrom, Jaana
    Mustonen, Harri
    Seppanen, Hanna
    Haglund, Caj
    Jirstrom, Karin
    Larsson, Anna H.
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345